376 related articles for article (PubMed ID: 30583701)
1. The rise of human stem cell-derived natural killer cells for cancer immunotherapy.
Wang K; Han Y; Cho WC; Zhu H
Expert Opin Biol Ther; 2019 Feb; 19(2):141-148. PubMed ID: 30583701
[TBL] [Abstract][Full Text] [Related]
2. Engineered human pluripotent stem cell-derived natural killer cells: the next frontier for cancer immunotherapy.
Zhu H; Kaufman DS
Blood Sci; 2019 Aug; 1(1):4-11. PubMed ID: 35402797
[TBL] [Abstract][Full Text] [Related]
3. An Improved Method to Produce Clinical-Scale Natural Killer Cells from Human Pluripotent Stem Cells.
Zhu H; Kaufman DS
Methods Mol Biol; 2019; 2048():107-119. PubMed ID: 31396935
[TBL] [Abstract][Full Text] [Related]
4. Anticancer cellular immunotherapies derived from umbilical cord blood.
Balassa K; Rocha V
Expert Opin Biol Ther; 2018 Feb; 18(2):121-134. PubMed ID: 29103317
[TBL] [Abstract][Full Text] [Related]
5. Reformation in chimeric antigen receptor based cancer immunotherapy: Redirecting natural killer cell.
Lin C; Zhang J
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):200-215. PubMed ID: 29378229
[TBL] [Abstract][Full Text] [Related]
6. Current Perspectives on "Off-The-Shelf" Allogeneic NK and CAR-NK Cell Therapies.
Heipertz EL; Zynda ER; Stav-Noraas TE; Hungler AD; Boucher SE; Kaur N; Vemuri MC
Front Immunol; 2021; 12():732135. PubMed ID: 34925314
[TBL] [Abstract][Full Text] [Related]
7. Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells.
Saetersmoen ML; Hammer Q; Valamehr B; Kaufman DS; Malmberg KJ
Semin Immunopathol; 2019 Jan; 41(1):59-68. PubMed ID: 30361801
[TBL] [Abstract][Full Text] [Related]
8. Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities.
Hu W; Wang G; Huang D; Sui M; Xu Y
Front Immunol; 2019; 10():1205. PubMed ID: 31214177
[TBL] [Abstract][Full Text] [Related]
9. iPSC-Derived Natural Killer Cell Therapies - Expansion and Targeting.
Goldenson BH; Hor P; Kaufman DS
Front Immunol; 2022; 13():841107. PubMed ID: 35185932
[TBL] [Abstract][Full Text] [Related]
10. Stem cells-derived natural killer cells for cancer immunotherapy: current protocols, feasibility, and benefits of ex vivo generated natural killer cells in treatment of advanced solid tumors.
Khodayari H; Khodayari S; Ebrahimi E; Hadjilooei F; Vesovic M; Mahmoodzadeh H; Saric T; Stücker W; Van Gool S; Hescheler J; Nayernia K
Cancer Immunol Immunother; 2021 Dec; 70(12):3369-3395. PubMed ID: 34218295
[TBL] [Abstract][Full Text] [Related]
11. Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer.
Mehta RS; Rezvani K
Front Immunol; 2018; 9():283. PubMed ID: 29497427
[TBL] [Abstract][Full Text] [Related]
12. Chimeric antigen receptor (CAR)-transduced natural killer cells in tumor immunotherapy.
Hu Y; Tian ZG; Zhang C
Acta Pharmacol Sin; 2018 Feb; 39(2):167-176. PubMed ID: 28880014
[TBL] [Abstract][Full Text] [Related]
13. Exploring the NK cell platform for cancer immunotherapy.
Myers JA; Miller JS
Nat Rev Clin Oncol; 2021 Feb; 18(2):85-100. PubMed ID: 32934330
[TBL] [Abstract][Full Text] [Related]
14. Enhancing a Natural Killer: Modification of NK Cells for Cancer Immunotherapy.
Islam R; Pupovac A; Evtimov V; Boyd N; Shu R; Boyd R; Trounson A
Cells; 2021 Apr; 10(5):. PubMed ID: 33946954
[TBL] [Abstract][Full Text] [Related]
15. NK cell-based immunotherapy for malignant diseases.
Cheng M; Chen Y; Xiao W; Sun R; Tian Z
Cell Mol Immunol; 2013 May; 10(3):230-52. PubMed ID: 23604045
[TBL] [Abstract][Full Text] [Related]
16. Preclinical Assessment of Suitable Natural Killer Cell Sources for Chimeric Antigen Receptor Natural Killer-Based "Off-the-Shelf" Acute Myeloid Leukemia Immunotherapies.
Kloess S; Oberschmidt O; Dahlke J; Vu XK; Neudoerfl C; Kloos A; Gardlowski T; Matthies N; Heuser M; Meyer J; Sauer M; Falk C; Koehl U; Schambach A; Morgan MA
Hum Gene Ther; 2019 Apr; 30(4):381-401. PubMed ID: 30734584
[TBL] [Abstract][Full Text] [Related]
17. Natural Killer Cells and Current Applications of Chimeric Antigen Receptor-Modified NK-92 Cells in Tumor Immunotherapy.
Zhang J; Zheng H; Diao Y
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646574
[TBL] [Abstract][Full Text] [Related]
18. Natural Killer Cells: Angels and Devils for Immunotherapy.
Martín-Antonio B; Suñe G; Perez-Amill L; Castella M; Urbano-Ispizua A
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28850071
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of natural killer cells in cancer therapy and transplantation.
Knorr DA; Bachanova V; Verneris MR; Miller JS
Semin Immunol; 2014 Apr; 26(2):161-72. PubMed ID: 24618042
[TBL] [Abstract][Full Text] [Related]
20. Boosting Natural Killer Cell-Based Immunotherapy with Anticancer Drugs: a Perspective.
Cifaldi L; Locatelli F; Marasco E; Moretta L; Pistoia V
Trends Mol Med; 2017 Dec; 23(12):1156-1175. PubMed ID: 29133133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
